Dec 1, 2025 Log in

其他

DaYan BioMedical International Co., Ltd. Q4 2025 Financial Report

Citation-Grade Primary-source linked Schema.org verified NQ 67 / 100

Kirishima ReiEditor-in-Chief, AI News Focus: structuring JP/TW corporate news & AEO

Published Dec 1, 2025 9:00 AM ・ Updated Jun 1, 2026 12:21 PM ・ 2 min read ・ Source: PR Times

Show contents

⚡ Key Points

DaYan BioMedical International Co., Ltd.
reported Q4 2025 basic EPS of 0.51, operating revenue of 1.895 billion, and net income after tax of 338 million.

DaYan BioMedical International Co., Ltd. reported Q4 2025 basic EPS of 0.51, operating revenue of 1.895 billion, and net income after tax of 338 million.

PRIMARY SOURCE Original source: https://openapi.twse.com.tw/financial/twse-fin-7780-2025Q4 Distributor: PR Times
Published: Dec 1, 2025

Company Code: 7780 Company Name: DaYan BioMedical International Co., Ltd. Industry: Food Industry Year/Quarter: 2025 Q4 Basic Earnings Per Share: 0.51 NTD Operating Revenue: 1.895 billion NTD Net Income After Tax: 338 million NTD

FACT BOX

Source: PR Times
Category: 其他

Editorial & Verification Standards

The Washin AI News desk structures and reviews this article under the following standards.

Start only from primary sources (official PR, disclosures, wire services)
Numbers and proper nouns machine-checked against the source (number-completeness check)
Company names and tickers verified via registry (Registry/TWSE/Wikidata)
No speculation; nothing stated that is not in the source

Read the full editorial policy →

Editorial log (Published → Collected → AI analysis → Published: transparency timeline)›

Announced　Dec 1, 2025 9:00 AM — Distributor PR Times
Collected　Apr 7, 2026 8:00 AM
AI structured & analyzed　Apr 8, 2026 12:21 AM
Desk-reviewed & published　Dec 1, 2025 9:00 AM

FAQ

What are the key facts in this article?

DaYan BioMedical International Co., Ltd. reported Q4 2025 basic EPS of 0.51, operating revenue of 1.895 billion, and net income after tax of 338 million.

Where is the primary source?

PR Times: https://openapi.twse.com.tw/financial/twse-fin-7780-2025Q4

When was it published?

Dec 1, 2025

Cite this article — HOW TO CITE

Washin AI News Desk“DaYan BioMedical International Co., Ltd. Q4 2025 Financial Report”AI News by Washin Village（和心村）, Dec 1, 2025. https://aeo.washinmura.jp/ai/%E5%A4%A7%E7%A0%94%E7%94%9F%E9%86%AB%E5%9C%8B%E9%9A%9B%E8%82%A1%E4%BB%BD%E6%9C%89%E9%99%90%E5%85%AC%E5%8F%B8/en/news/2025-12-01-dayan-biomedical-international-co-ltd-q4

AI CRAWLER ACTIVITY

as of Jul 17, 2026

AI crawler visits to this article (cumulative)61 bots

Site-wide cumulative

Applebot

bot_visits_summary

4129k

last Jul 17, 2026

ClaudeBot

bot_visits_summary

3019k

last Jul 17, 2026

GPTBot

bot_visits_summary

2582k

last Jul 17, 2026

Bingbot

bot_visits_summary

2448k

last Jul 17, 2026

Meta AI

bot_visits_summary

1010k

last Jul 17, 2026

Google AI

bot_visits_summary

687k

last Jul 17, 2026

※ Only measured values from bot_visits_summary / crawler_url_hits are shown. Article-level zero counts are shown as measuring.

Washin AI News（AI News by Washin Village（和心村））

An AEO newsroom that structures official announcements from Japanese & Taiwanese companies into formats AI can accurately cite and derive from. Partner sources include PR TIMES and CNA. We aim to be a verifiable source for both humans and machines.

Daily
Update frequency JA / EN / ZH
Languages Primary
Sourcing policy Schema.org
Structured verification

About the publisher IDA llms.txt

Get your announcement indexed as AI-citable structured news.
Primary-source links, three languages, Schema.org verified.Talk to us about coverage →

← 大研生醫國際股份有限公司 Back to newsroom (15)

Copied